Search Within

Population Sciences Research Program

  1. "Nursing"
  2. "Meeting abstract"
  3. "Dermatology Service"
Formats
  1. Meeting Abstract (11)
Groups
  1. Department of Medicine (11)
  2. Dermatology (11)
  3. Dermatology Service (11)
  4. Division of Subspecialty Medicine (11)
  5. Nursing (11)
  6. Center for Hematologic Malignancies (8)

More Groups

People
  1. Patricia Myskowski (8)
  2. Steven Horwitz (8)
  3. Alison Moskowitz (7)
  4. Andrew Zelenetz (4)
  5. David Straus (4)
  6. John Gerecitano (4)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (2)
  6. 2014 (1)

More Years

Publications
  1. Blood (4)
  2. Hematological Oncology (2)
  3. Journal of Clinical Oncology (2)
  4. Journal of Investigative Dermatology (2)
  5. Cancer Research (1)
Publishers
  1. American Society of Hematology (4)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Science, Inc. (2)
  4. Wiley Blackwell (2)
  5. American Association for Cancer Research (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of reduced dose brentuximab vedotin for cutaneous T‐cell lymphomas
    Meeting Abstract

    Khan, N.; Noor, S.; Geller, S.; Khodadoust, M. S.; Kheterpal, M.; Hancock, H.; Davey, T.; Ryu, S.; Perez, L.; Lares, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma
    Meeting Abstract

    Mehta-Shah, N; Lunning, M. A.; Boruchov, A. M.; Ruan, J.; Nair, S.; Lynch, P.; Byrne, R.; Moskowitz, A. J.; Matasar, M. J.; Gerecitano, J. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results
    Meeting Abstract

    Lunning, M. A.; Ruan, J.; Nair, S.; Boruchov, A. M.; Byrne, R.; Gerecitano, J. F.; Hamlin, P. A.; Inserra, B.; Leonard, J.; Lynch, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Results of a phase II trial of oral bexarotene combined with interferon alfa-2b for patients with cutaneous T-cell lymphoma (CTCL)
    Meeting Abstract

    Straus, D. J.; Duvic, M.; Kozel, T.; Horwitz, S.; Demierre, M. F.; Myskowski, P.; Maignan, K.; Steckel, S.
    Blood (2004)

    Fulltext@MSK | Save
  • Factors associated with skin self-examination in an intervention study
    Meeting Abstract

    Oliveria, S. A.; Dusza, S. W.; Hay, J.; Phelan, D.; Halpern, A. C.
    Journal of Investigative Dermatology (2004)

    Fulltext@MSK | Save